急性脑卒中患者再灌注治疗后CT脑实质高密度影的临床意义解读
回顾性纳入三家医院165例前循环急性卒中再灌注治疗患者,治疗后24-30小时CT上41%出现脑实质高密度影(CTHD),其中63%发生出血转化,95%演变为最终缺血区;穿刺至再通时间是CTHD的独立预测因素,CTHD是3个月mRS临床结局的独立预后因素。
要点
- 再灌注治疗后24-30小时CT出现脑实质高密度影(CTHD)提示临床结局较差。
- CTHD多数演变为最终缺血脑区,部分发生出血转化,出血转化者结局更差。
- 穿刺至再通时间越长,CTHD出现风险越高。
核心结论
- 再灌注治疗后24-30小时CT上出现CTHD是临床结局较差的独立预后因素,与基线ASPECT评分及是否发生出血转化无关。
研究设计与样本
- 回顾性纳入三家医院165例前循环急性卒中再灌注治疗患者,评估治疗前、治疗后24-30小时、24-72小时及1个月随访CT。
关键影像表现/征象
- 治疗后24-30小时CT上68例(41%)出现脑实质高密度影(CTHD)。
- 治疗后24-72小时CT上43例(63%)CTHD发生出血转化。
- 68例CTHD中65例(95%)演变为最终缺血脑区。
诊断标准与关键数值
- 多因素统计分析显示穿刺至再通时间是预测CTHD存在的唯一独立因素(p=0.045)。
- 首次治疗后CT出现CTHD是3个月随访mRS评分所定临床结局的独立因素(p=0.05)。
- 随访CT上出血转化者结局较CTHD缺血演变者更差(p=0.01)。
临床应用与阅片要点
- 阅片时注意识别再灌注治疗后24-30小时CT上的脑实质高密度影,并随访其演变。
- 报告中可关注穿刺至再通时间,其与CTHD出现相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the clinical meaning of brain parenchymal computed-tomography hyperdensities (CTHD) in patients treated of anterior circulation acute stroke with reperfusion therapy.
METHODS: Patients were retrospectively enrolled from three different hospitals. Brain CT scans were assessed at four time points: We recorded ASPECT scores of pre-treatment CTs, assessed ASPECT scores and the presence of CTHD on post-treatment CTs acquired within 24-30 h and 24-72 h, and examined a one-month CTs follow-up to determine the ischemic evolution of CTHD. We correlated the presence of CTHD with clinical and radiological data to define its predictive and prognostic factors.
RESULTS: In total, 165 patients were evaluated. At post-treatment CTs acquired within 24-30 h, 68 (41%) patients showed the presence of CTHD. On post-treatment CTs acquired within 24-72 h, 43 (63%) of the CTHD showed hemorrhagic transformation. Sixty-five (95%) out of the 68 CTHD evolved in a final ischemic brain area. Multivariate statistical analysis identified puncture to recanalization time to be the only independent factors predicting the presence of CTHD (p = 0.045). The presence of CTHD at the first post-treatment CTs was an independent factor for clinical outcome determined with mRS scores at 3-month follow-up (p = 0.05). Outcomes were worse for hemorrhagic transformation at follow-up CTs compared to the ischemic evolution of the CTHD (p = 0.01).
CONCLUSIONS: The presence of CTHD at CTs imaging acquired within 24-30 h after reperfusion therapy is an independent prognostic factor of a worse clinical outcome, regardless of its ASPECT score at baseline CTs and of its hemorrhagic evolution.
引用
- Calloni, Panni, Calabrese, et al. Cerebral hyperdensity on CT imaging (CTHD) post-reperfusion treatment in patients with acute cerebral stroke: understanding its clinical meaning. Radiol Med. 2022. PMID: 35879628. doi:10.1007/s11547-022-01525-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。